The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function
Abstract
Many tumor cells shed specialized membrane vesicles known as exosomes. In this study, we show that pretreatment of mice with exosomes produced by TS/A or 4T.1 murine mammary tumor cells resulted in accelerated growth of implanted tumor cells in both syngeneic BALB/c mice and nude mice. As implanted TS/A tumor cells grew more rapidly in mice that had been depleted of NK cells, we analyzed the effects of the tumor-derived exosomes on NK cells. The tumor-derived exosomes inhibit NK cell cytotoxic activity ex vivo and in vitro as demonstrated by chromium release assays. The treatment of mice with TS/A tumor exosomes also led to a reduction in the percentages of NK cells, as determined by FACS analysis, in the lungs and spleens. Key features of NK cell activity were inhibited, including release of perforin but not granzyme B, as well as the expression of cyclin D3 and activation of the Jak3-mediated pathways. Human tumor cell lines also were found to produce exosomes that were capable of inhibiting IL-2-stimulated NK cell proliferation. Exosomes produced by dendritic cells or B cells did not. The presentation of tumor Ags by exosomes is under consideration as a cancer vaccine strategy; however, we found that pretreatment of mice with tumor exosomes blunted the protective effect of syngeneic dendritic cells pulsed ex vivo with tumor exosomes. We propose that tumor exosomes contribute to the growth of tumors by blocking IL-2-mediated activation of NK cells and their cytotoxic response to tumor cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exosomes: composition, biogenesis and function
Théry, C., Zitvogel, L., & Amigorena, S. (2002) · Nature Reviews Immunology · doi:10.1038/nri855 · Cited by 5,346
Identification and proteomic profiling of exosomes in human urine
Pisitkun, T., Shen, R.-F., & Knepper, M. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403453101 · Cited by 2,174
Kägi, D., Ledermann, B., Bürki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M., & Hengartner, H. (1994) · Nature · doi:10.1038/369031a0 · Cited by 1,757
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Théry, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T., et al. (2001) · Nature Medicine · doi:10.1038/85438 · Cited by 1,640
Cells release prions in association with exosomes
Fevrier, B., Vilette, D., Archer, F., Loew, D., Faigle, W., Vidal, M., Laude, H., & Raposo, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308413101 · Cited by 997
Indirect activation of naïve CD4+ T cells by dendritic cell–derived exosomes
Théry, C., Duban, L., Segura, E., Véron, P., Lantz, O., & Amigorena, S. (2002) · Nature Immunology · doi:10.1038/ni854 · Cited by 960
Functional Activation of Jak1 and Jak3 by Selective Association with IL-2 Receptor Subunits
Miyazaki, T., Kawahara, A., Fujii, H., Nakagawa, Y., Minami, Y., Liu, Z.-J., Oishi, I., Silvennoinen, O., Witthuhn, B. A., Ihle, J. N., et al. (1994) · Science · doi:10.1126/science.7973659 · Cited by 589
André, F., Chaput, N., Schartz, N. E. C., Flament, C., Aubert, N., Bernard, J., Lemonnier, F., Raposo, G., Escudier, B., Hsu, D.-H., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2126 · Cited by 496
Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects
Taylor, D. D., & Gerçel-Taylor, C. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602316 · Cited by 391
The role of Stat5a and Stat5b in signaling by IL-2 family cytokines
Lin, J.-X., & Leonard, W. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203523 · Cited by 368
Proteomic Analysis of Exosomes Secreted by Human Mesothelioma Cells
Hegmans, J. P. J. J., Bard, M. P. L., Hemmes, A., Luider, T. M., Kleijmeer, M. J., Prins, J.-B., Zitvogel, L., Burgers, S. A., Hoogsteden, H. C., & Lambrecht, B. N. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63739-x · Cited by 349
Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma
Doubrovina, E. S., Doubrovin, M. M., Vider, E., Sisson, R. B., O’Reilly, R. J., Dupont, B., & Vyas, Y. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6891 · Cited by 324
Perforin Is a Major Contributor to NK Cell Control of Tumor Metastasis
Smyth, M. J., Thia, K. Y. T., Cretney, E., Kelly, J. M., Snook, M. B., Forbes, C. A., & Scalzo, A. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6658 · Cited by 295
Tumor-induced immune dysfunction
Kiessling, R., Wasserman, K., Horiguchi, S., Kono, K., Sjöberg, J., Pisa, P., & Petersson, M. (1999) · Cancer Immunology, Immunotherapy · doi:10.1007/s002620050586 · Cited by 237
PLD2 is enriched on exosomes and its activity is correlated to the release of exosomes
Laulagnier, K., Grand, D., Dujardin, A., Hamdi, S., Vincent-Schneider, H., Lankar, D., Salles, J.-P., Bonnerot, C., Perret, B., & Record, M. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.06.082 · Cited by 229
Tumor-derived exosomes: a new source of tumor rejection antigens
André, F., Schartz, N. E. C., Chaput, N., Flament, C., Raposo, G., Amigorena, S., Angevin, E., & Zitvogel, L. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00384-5 · Cited by 220
NKT cells and tumor immunity—a double-edged sword
Smyth, M. J., & Godfrey, D. I. (2000) · Nature Immunology · doi:10.1038/82698 · Cited by 209
Hayakawa, Y., Kelly, J. M., Westwood, J. A., Darcy, P. K., Diefenbach, A., Raulet, D., & Smyth, M. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5377 · Cited by 185
Localization of the Epstein–Barr virus protein LMP 1 to exosomes
Flanagan, J., Middeldorp, J., & Sculley, T. (2003) · Journal of General Virology · doi:10.1099/vir.0.18944-0 · Cited by 172
MHC class I down-regulation: tumour escape from immune surveillance? (Review)
Bubeník, J. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.2.487 · Cited by 167
Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12
Kodama, T., Takeda, K., Shimozato, O., Hayakawa, Y., Atsuta, M., Kobayashi, K., Ito, M., Yagita∥, H., & Okumura, K. (1999) · European Journal of Immunology · Cited by 155
Buggins, A. G. S., Milojković, D., Arno, M. J., Lea, N. C., Mufti, G. J., Thomas, N. S. B., & Hirst, W. J. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.6021 · Cited by 155
IL-21 Induces Tumor Rejection by Specific CTL and IFN-γ-Dependent CXC Chemokines in Syngeneic Mice
Carlo, E. D., Comes, A., Orengo, A. M., Rosso, O., Meazza, R., Musiani, P., Colombo, M. P., & Ferrini, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1540 · Cited by 153
Role of natural killer cells in cancer.
Pross, H. F., & Lotzová, E. (1994) · PubMed · Cited by 151
Immunologic mechanisms of antitumor activity
Foss, F. M. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.33076 · Cited by 136
Perioperative Immunosuppression in Cancer Patients
Vallejo, R., Hord, E. D., Barna, S. A., Santiago‐Palma, J., & Ahmed, S. U. (2003) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvpathtoxoncol.v22.i2.70 · Cited by 114
HLA-G and IL-10 expression in human cancer--different stories with the same message.
Urosevic, M., & Dummer, R. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(03)00024-5 · Cited by 113
Role of TGF-? in immune-evasion of cancer
Beck, C., Schreiber, H. W., & Rowley, D. A. (2001) · Microscopy Research and Technique · doi:10.1002/1097-0029(20010215)52:4<387::aid-jemt1023>3.0.co;2-w · Cited by 106
Reflections on STAT3, STAT5, and STAT6 as fat STATs.
Darnell, J. E., Jr. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6221 · Cited by 103
Cutting Edge: Granzymes A and B Are Not Essential for Perforin-Mediated Tumor Rejection
Smyth, M. J., Street, S. E. A., & Trapani, J. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.515 · Cited by 99
López‐Botet, M., Angulo, A., & Gumá, M. (2004) · Tissue Antigens · doi:10.1111/j.1399-0039.2004.00210.x · Cited by 97
Liu, Z., Xu, X., Hsu, H., Tousson, A., Yang, P., Wu, Q., Liu, C., Yu, S., Zhang, H., & Mountz, J. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319209 · Cited by 97
Self-citationNovel tumor necrosis factor α–regulated genes in rheumatoid arthritis
Zhang, H., Hyde, K., Page, G. P., Brand, J. P. L., Zhou, J., Yu, S., Allison, D. B., Hsu, H., & Mountz, J. D. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20037 · Cited by 74
Self-citationRakhmilevich, A. L., Janssen, K., Hao, Z., et al. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700176 · Cited by 68
Exosomes for Immunotherapy of Cancer
Chaput, N., Schartz, N., André, F., & Zitvogel, L. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0081-0_17 · Cited by 55
Jović, V., Konjević, G. M., Radulovic, S. S., Jelić, S., & Spužić, I. (2001) · Tumori Journal · doi:10.1177/030089160108700509 · Cited by 45
Dong, F., Cress, W. D., Agrawal, D., & Pledger, W. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6190 · Cited by 44
NKG2D and Related Immunoreceptors
Strong, R. K., & McFarland, B. J. (2004) · Advances in protein chemistry · doi:10.1016/s0065-3233(04)68008-9 · Cited by 41
Myeloma and the newly diagnosed patient: A focus on treatment and management
Rajkumar, S. V., Kyle, R. A., & Gertz, M. A. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70054-7 · Cited by 37
Hepatic DR5 Induces Apoptosis and Limits Adenovirus Gene Therapy Product Expression in the Liver
Zhang, H., Xie, J., Xu, L., Yang, P., Xu, X., Sun, S. L., Wang, Y., Curiel, D. T., Hsu, H., & Mountz, J. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5692-5700.2002 · Cited by 34
Self-citationBXD recombinant inbred mice represent a novel T cell–mediated immune response tumor model
Grizzle, W. E., Mountz, J. D., Yang, P., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10606 · Cited by 33
Self-citationZhang, H., Yang, P., Xie, J., Liu, Z., Liu, D., Liang, X., Zhou, T., Wang, Y., Hsu, H., & Mountz, J. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.4164 · Cited by 33
Self-citationChiang, E. Y., Henson, M., & Stroynowski, I. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4515 · Cited by 32
Immune Cell Functions in Pancreatic Cancer
PLATE, J. M. D., & Harris, J. E. (2000) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v20.i5.20 · Cited by 23
Есартия, П. Т., Deichman, G. I., Kluchareva, T. E., Матвеева, В. А., Уварова, Э. Н., & Trapesnikov, N. N. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540606 · Cited by 11
Research works printed but not linked: 51
- 2003, J. Immunol., 4515
- 2003, J. Immunol., 1715
- 2003, J. Immunol., 6891
- 2001, Microsc. Res. Tech., 387
- 2003, Semin. Cancer Biol., 337
- 2001, Immunol. Invest., 143
- 2001, J. Immunol., 6021
- 2002, Vaccine, A28
- 2001, Nat. Med., 297
- 2004, Proc. Natl. Acad. Sci. USA, 9683
- 2003, J. Gen. Virol., 1871
- 2004, Am. J. Pathol., 1807
- 2004, Proc. Natl. Acad. Sci. USA, 13368
- 2002, Nat. Rev. Immunol., 569
- 2002, Nat. Immunol., 1156
- 2005, Br. J. Cancer, 305
- 2002, Int. J. Cancer, 270
- 2003, J. Clin. Invest., 1332
- 2002, J. Virol., 5692
- 2004, Arthritis Rheum., 420
- 2002, J. Immunol., 4164
- 1985, Laryngoscope, 588
- 1999, Neoplasma, 54
- 2003, J. Am. Coll. Surg., 254
- 1993, Int. J. Cancer, 907
- 1993, Nat. Immun., 279
- 2004, J. Immunol., 1540
- 2000, Cancer Gene Ther., 826
- 2004, Int. J. Oncol., 487
- 2004, Tissue Antigens, 195
- 2004, Adv. Protein Chem., 281
- 1994, Nature, 31
- 2001, Tumori, 324
- 1999, J. Immunol., 6658
- 1999, Eur. J. Immunol., 1390
- 2003, J. Immunol., 515
- 2000, Nat. Immunol., 459
- 1999, J. Formos. Med. Assoc., 730
- 1999, Cancer Immunol. Immunother., 353
- 2000, Crit. Rev. Immunol., 375
- 2002, Semin. Oncol., 5
- 2003, J. Environ. Pathol. Toxicol. Oncol., 139
- 2003, Adv. Exp. Med. Biol., 215
- 2004, FEBS Lett., 11
- 2002, J. Immunol., 5377
- 2002, Eur. J. Immunol., 793
- 2000, Oncogene, 2566
- 1994, Science, 1045
- 1996, Proc. Natl. Acad. Sci. USA, 6221
- 1998, J. Biol. Chem., 6190
- 2004, J. Immunol., 2126
Cited by
Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
Membrane vesicles as conveyors of immune responses
Théry, C., Ostrowski, M., & Segura, E. (2009) · Nature Reviews Immunology · doi:10.1038/nri2567 · Cited by 3,882
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
Becker, A., Thakur, B. K., Weiss, J. M., Kim, H. S., Peinado, H., & Lyden, D. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.009 · Cited by 2,003
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., & Nieuwland, R. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005983 · Cited by 1,754
Metadata
- Authors
- Liu, C., Yu, S., Zinn, K., Wang, J., Zhang, L., Jia, Y., Kappes, J. C., Barnes, S., Kimberly, R. P., Grizzle, W. E., & Zhang, H.-G.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-02-01
- Volume
- 176
- Issue
- 3
- Pages
- 1375-1385
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2124104087
- Cited by
- 500
- References
- 45
- FWCI
- 6.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.